STRAGEN NORDIC A/S: Financial statements 2013
CVR: 26717825
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,586,066 and a net result of DKK -292,716 compared with DKK -2,789,164 the year before. That is an increase of 119.1% compared with the year before. Equity in the 2013 report amounted to DKK 2,675,739. The solvency ratio was 22.2%.
- Gross Profit
- DKK 4,586,066
- Profit/Loss
- DKK -292,716
- Equity
- DKK 2,675,739
- Total Assets
- DKK 12,063,715
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 4.6M | -293K | 2.7M | - |
| 2012 | 39.5M | 2.1M | -2.8M | 3M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
STRAGEN NORDIC A/S has published its annual report for 2012. Revenue came to DKK 39,507,656, and the net result was DKK -2,789,164.
As of May 19, 2013, Yves Josef Gaby Decadt has joined the board of directors of STRAGEN NORDIC A/S.
As of May 19, 2013, Jean-Luc Tetard has left the board of directors of STRAGEN NORDIC A/S.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.
